Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Milica Radojkovic"'
Autor:
Milica Radojkovic
Publikováno v:
Medical review. 75:62-65
Over the last 10-15 years, the prognosis of patients with follicular lymphoma has improved, and for the majority of patients, follicular lymphoma is a chronic disease with ten years of overall survival of around 80%. Nevertheless, a certain subset of
Autor:
Milica Vukotić, Olivera Mitrović Ajtić, Vladan P. Čokić, Dragoslava Đikić, Suncica Kapor, Juan F. Santibanez, Tijana Subotički, Milica Radojkovic
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 11
Journal of Personalized Medicine, Vol 11, Iss 1048, p 1048 (2021)
Volume 11
Issue 11
Journal of Personalized Medicine, Vol 11, Iss 1048, p 1048 (2021)
Hydroxyurea (HU) is an antineoplastic agent that functions as an antimetabolite compound by inhibiting the ribonucleotide reductase. HU acts mainly as a cytostatic drug that through DNA replication stress may trigger a premature senescence-like cell
Autor:
Marija Dencic-Fekete, Tatjana Terzic, Ljubomir Jakovic, Vladislava Djurasinovic, Djurasevic Karan, Milica Radojkovic, Sonja Pavlovic, Andrija Bogdanovic
Publikováno v:
Vojnosanitetski pregled. :60-60
Introduction. The presence of aneuploidy in patients with chronic lymphocytic leukemia (CLL), except trisomy 12, is quite uncommon. The frequency of hyperdiploidy or near-tetraploidy ocurrs in 1-3% of the CLL patients and usually confer poor prognosi
Publikováno v:
Vojno delo. 68:212-220
Internal audit is an established independent, highly professional and objective, assessing and advisory activity, which is done in order to provide the management with services in order to create new value and improve the business. It achieves its ob
Autor:
Milica Radojkovic, Vesna Spasovski, Vesna Cemerikic-Martinovic, Slobodan Ristic, Tatjana Kostic, Sonja Pavlovic
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 143, Iss 11-12, Pp 739-743 (2015)
Srpski arhiv za celokupno lekarstvo (2015) 143(11-12):739-743
Srpski arhiv za celokupno lekarstvo (2015) 143(11-12):739-743
Introduction. Secondary malignancies, particularly solid tumors, are common in patients with chronic lymphocytic leukemia (CLL), but association of myeloproliferative neoplasms and chronic lymphocytic leukemia in the same patient is very rare. Case O
Publikováno v:
Vojno delo. 66:238-254
The basic concept of control is to create a process that ensures the achievement of objectives with appropriate quality, funds preservation and management in compliance with law and other regulations and procedures, and the preparation and developmen
Autor:
Milica Radojkovic, Mila Puric, Goran Trajkovic, Irena Glumac, Zoran Milojevic, Natasa Tosic, Darko Antic, Marija Dencic Fekete, Jelena Bila, Olivera Markovic, Milena Todorovic Balint, Biljana Mihaljevic, Jelena Jelicic, Sonja Pavlovic, Aleksandra Sretenovic
Publikováno v:
Clinical lymphoma, myelomaleukemia. 16(11)
Background To personalize the treatment approach for patients with multiple myeloma (MM), molecular markers such as cereblon ( CRBN ) are currently the focus of investigation. The aim of the present study was to test the prognostic significance of CR
Autor:
Milica Colovic, Henry Dushan Atkinson, Nada Suvajdzic, Dragica Tomin, Milica Radojkovic, Gradimir Jankovic, Natasa Colovic, Nada Kraguljac, Dejana Stanisavljevic, Ana Vidovic
Publikováno v:
Annals of Hematology. 91:1363-1370
A retrospective survey of 210 consecutive patients aged ≥65 years (median age 69 years, range 65–88 years) with acute myeloid leukemia (AML) diagnosed at a single center over a 6-year period (January 2001 to December 2006) is presented. De novo A
Publikováno v:
Vojnosanitetski Pregled, Vol 68, Iss 5, Pp 444-446 (2011)
Vojnosanitetski pregled (2011) 68(5):444-446
Vojnosanitetski pregled (2011) 68(5):444-446
Introduction. Systemic mastocytosis is a heterogeneous group of hematological disorders characterized by accumulation of mast cells in different organs. Case report. A 41-year-old woman presented with a three-year history of fatigue, occasional diarr
Autor:
Paolo Fagone, Mirna Bulatović, Djordje Miljković, Ferdinando Nicoletti, Massimo Libra, Eugenio Cavalli, Marija Mojić, James A. McCubrey, Stanislava Stosic-Grujicic, Danijela Maksimović-Ivanić, Milos Kuzmanovic, Slobodan Ristic, Sanja Mijatović, Milica Radojkovic
Publikováno v:
Leukemia Research
Covalent attachment of NO to the first approved HIV protease inhibitor Saquinavir (Saq-NO) expands the therapeutic potential of the original drug. Apart from retained antiviral activity, the modified drug exerts strong antitumor effects and lower tox